Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Green Thumb Industries

Market Cap: CA$2.4b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Bright Minds Biosciences

Market Cap: CA$831.3m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Eupraxia Pharmaceuticals

Market Cap: CA$599.0m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Verano Holdings

Market Cap: CA$593.9m

Engages in the cannabis business in the United States.

Canopy Growth

Market Cap: CA$574.0m

Engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally.

Cresco Labs

Market Cap: CA$522.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Spectral Medical

Market Cap: CA$399.0m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

TerrAscend

Market Cap: CA$358.1m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

High Tide

Market Cap: CA$287.3m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Organigram Global

Market Cap: CA$194.3m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Cardiol Therapeutics

Market Cap: CA$172.9m

A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Satellos Bioscience

Market Cap: CA$169.4m

A clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.

HLS Therapeutics

Market Cap: CA$134.2m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.

Medexus Pharmaceuticals

Market Cap: CA$130.8m

Operates as a pharmaceutical company in Canada and the United States.

Decibel Cannabis

Market Cap: CA$69.2m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Vext Science

Market Cap: CA$64.4m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

Planet 13 Holdings

Market Cap: CA$60.8m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Sernova Biotherapeutics

Market Cap: CA$60.4m

Operates as a clinical-stage biotechnology company in Canada.

Optimi Health

Market Cap: CA$39.9m

Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

Medicenna Therapeutics

Market Cap: CA$39.7m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

Rubicon Organics

Market Cap: CA$29.7m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Delivra Health Brands

Market Cap: CA$3.3m

Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.